Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

US regulators clear way for more monkeypox vaccine shipments

U.S. officials say thousands more doses of the monkeypox vaccine could soon begin shipping from Denmark

The Independent UK

FDA Approves Novavax COVID-19 Vaccine, but Feds Undecided on Who It's for

Plus: The story of a 10-year-old rape victim who sought an abortion is confirmed, inflation hits a record 9.1 percent, and more...

Reason

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

An expert panel has recommended against taking vitamin E or beta carotene supplements for the prevention of cancer and cardiovascular disease – here's why

The U.S. Preventive Services Task Force issued a recommendation statement in June 2022 on the use of over-the-counter vitamin supplements. Based on its independent panel of experts’ review of existing scientific evidence, the task force recommended against using beta carotene or vitamin E supplements for the prevention of cancer and…

The Conversation

Benzinga Before The Bell: Tesla's AI Exec Quits, Hyundai Unveils Ioniq 6 EV, Taiwan Semiconductor's Massive Q2 Profit Surge And Other Top Financial Stories Thursday, July 14

CNBC United Airlines, Pilots’ Union To Improve Agreement By Renegotiating

Benzinga

Abortion medications set to become next legal battlefield

In the nearly three weeks since the U.S. Supreme Court overturned Roe v. Wade, abortion has become illegal in at least 10 states, with more states to follow in the weeks ahead.

Tribune News Service

Over-the-counter birth control pills are available worldwide. The U.S. may be next

Birth control pills are available in the U.S. only with a prescription. Now a drugmaker is asking the FDA to approve a progestin-only contraceptive that would be available without one at pharmacies.

WEKU

Read news from The Economist, FT, and more,
with one subscription

FDA sends more than 100 warning letters to firms over new synthetic nicotine law

The FDA has vowed to take more action in the coming weeks.

Axios

Gateshead's Shield Therapeutics awaits Canadian regulatory approval for iron deficiency drug

The pharmaceutical firm says Health Canada will screen its Accrufer lead product, with an outcome expected next year

Birmingham Post

Novavax’s COVID vaccine gets US nod as latest pandemic weapon

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Tribune News Service

FDA authorizes protein-based Novavax Covid vaccine for adults

Approval of shot widens options against the virus as CDC will meet next week to decide whether to sign off on vaccine

The Guardian - US

US regulators OK new COVID-19 shot option from Novavax

The U.S. is getting another COVID-19 vaccine choice

The Independent UK

Novavax Covid vaccine becomes fourth to receive FDA approval

The protein-based vaccine still needs to be approved by the CDC before it can start to be administered

The Independent UK

FDA authorizes Novavax COVID vaccine for emergency use

"Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19."

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment

Ketamine pharmaceuticals provider PharmaTher Holdings Ltd. (OTCQB: PHRRF) has been granted a Notice of Allowance by the U.S.

Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Benzinga

Science Wednesday: Where To See Comet K2 As It Passes The Earth

Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across the universe, with a nucleus believed to be around 11 miles in diameter and a…

Reason

Poll: Only 26 Percent of Democrats Want Biden To Run in 2024

Plus: Psilocybin microdosing improves mood, vaping regulations backfire, and more...

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger

Inhale Success: Blakk Tatted Becomes Overnight Millionaire With Hookah Brand

NEW ORLEANS — Blakk Tatted loves the idea of being an overnight success.

Los Angeles Times

Will Americans have the right COVID-19 vaccine this fall? Maybe

In a few short months, the weather will turn crisp, the holiday season will draw near, and the coronavirus may embark on its third consecutive winter of death and devastation.

Benzinga

Boeing, PriceSmart And 80 Biggest Movers From Yesterday

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

The Philadelphia Inquirer

Why BA.5 is not a super-virus, and how the vaccines are still the best option against COVID

The BA.5 “subvariant” of the coronavirus has rapidly become dominant in the United States, and rising COVID-19 case numbers are dashing hopes for a summer break from the pandemic.

Reason

The U.S. Government Had What It Needed To Prevent the Spread of Monkeypox. It Happened Anyway.

Foot-dragging and red tape by the CDC and the FDA have fueled an avoidable outbreak.

Benzinga

Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?

Image sourced from Shutterstock

Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session

Gainers

1 … 199 200 201 202

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.